FDA Logo links to FDA home page
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On May 2, 2005
Table of Contents
Docket # Title
1980N-0208 Biological Products; Bacterial Vaccines and Toxiods
1980P-0100 LIGHT SHOW PROJECTOR "RAINBOW"
1995N-0304 Ephedrine Alkaloids: Reports of Adverse Events; Availability
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
1999N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings
1999P-1340 Declared Eternity eau de Parfum Misbranded
2000D-1598 Voluntary Labeling for Bioengineered Foods
2000N-1396 Bioengineered Foods Consumed By Humans or Animals
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
2000P-1322 Food Labeling and Allergen Contamination Control
2001N-0548 Guidelines for Voluntary Nutrition Labeling of Raw Fruits
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2001P-0230 Domestic Marketing & Importation of Transgenic Fish
2002N-0204 Bar Code Label Requirements for human drug products
2002P-0317 Recall Aspartame as a Neurotoxic Drug
2003D-0497 Guidance for Industry on Pharmacogenomic Data Submissions
2003F-0088 Increase the Maximum Permitted Energy Level of X-rays
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003P-0159 Venlafaxine Hydrochloride Extended-Release Tablets
2004D-0188 Guidance for Industry on Development and Use of Risk Minimization Action Plans
2004D-0510 Live & Perishable Fish & Fishery Products for Export to the European Union and the European Free Trade Association
2004N-0330 Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
2004N-0366 Working with Stakeholders on Scientific Opportunities for Facilitating Development of Vaccines, Blood and Blood Products, and Cellular, Tissue, and Gene Therapies
2004N-0454 Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
2004N-0456 Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
2004N-0559 Overall benefit to risk considerations for Cox-2 selective nonsteroidal anti-inflammatory drugs and related agents
2004Q-0151 Qualified Health Claim (QHC): soy protein and cancer
2005D-0004 Guidance for Industry on Nonclinical Safety Evaluation of Drug Combinations
2005D-0021 International Conference on Harmonisation; Draft Guidance on Q8 Pharmaceutical Development
2005D-0022 International Conference on Harmonisation; Draft Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals
2005D-0030 Guidance for Industry on Clinical Lactation Studies Study Design, Data Analysis, and Recommendations for Labeling
2005D-0103 Guidance for Industry on Using a Centralized IRB Process in Multicenter Clinical Trials
2005D-0155 Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials
2005M-0158 Bayer Healthcare, LLC; Premarket approval for ADVIA Centaur HBc IgM ReadyPack Reagents and ADVIA Centaur HBc IgM Quality Control Materials, P030040
2005M-0159 Ventana Medical Systems, Inc.; Premarket Approval of Ventana Medical Systems' Pathway Anti-c-KIT (9.7) Primary Antibody, P020055
2005M-0160 BioGenex Laboratories, Inc., Premarket Approval of InSite Her-2/neu kit, P040030
2005N-0038 Reporting of Adverse Events to Institutional Review Boards; Public Hearing
2005N-0065 Risk Assessment of the Public Health Impact from Foodborne Listeria monocytogenes in Smoked Finfish
2005N-0077 Color Additive Certification; Increase in Fees for Certification Services
2005N-0097 Agency Information Collection Activities: Proposed Collection; Comment Request;
2005P-0094 Remove the drug Iressa (gefitnib; AstraZeneca) from the market immediately
2005P-0166 to prevent the unlawful misbanding of prescription distance glasses and contact lenses
1980N-0208 Biological Products; Bacterial Vaccines and Toxiods
EC 44 Former Military - Army Vol #: 140
EMC 216 No signature Vol #: 156
EMC 217 No signature Vol #: 156
EMC 218 No signature Vol #: 156
EMC 219 No signature Vol #: 156
EMC 220 R. Fields, Sr. Vol #: 156
EMC 221 R. Fields, Sr. Vol #: 156
EMC 222 J. Stone Vol #: 156
EMC 223 J. Stone Vol #: 156
1980P-0100 LIGHT SHOW PROJECTOR "RAINBOW"
SUP 1 LFI International Vol #: 2
1995N-0304 Ephedrine Alkaloids: Reports of Adverse Events; Availability
EMC 1280 Mission Possible Intl Vol #: 399
EMC 1281 Mission Possible Intl Vol #: 399
EMC 1282 Mission Possible Intl Vol #: 399
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 15990 Natures Benefit, Inc. Vol #: 141
LET 15991 Natures Benefit, Inc. Vol #: 141
LET 15992 Natures Benefit, Inc. Vol #: 141
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
C 7476 J. Williams Vol #: 319
C 7477 J. Williams Vol #: 319
C 7478 J. Capozzelli Vol #: 319
EMC 4302 C. Goldstein Vol #: 320
EMC 4303 G. Falcone Vol #: 320
EMC 4304 Jessica A. Vol #: 320
EMC 4305 D. Bolbol Vol #: 320
EMC 4306 Mr and Mrs V and J Caracci Vol #: 320
EMC 4307 L. Friedberg Vol #: 320
EMC 4308 B. Rickus Vol #: 320
EMC 4309 J. Kahl Vol #: 320
EMC 4310 T. Schroeder Vol #: 320
EMC 4311 D. Cleven Vol #: 320
EMC 4312 T. Knight Vol #: 320
EMC 4313 E. Maupin Vol #: 320
EMC 4314 N. Mroueh Vol #: 320
1999N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings
C 18227 C. Wrlin Vol #: 516
1999P-1340 Declared Eternity eau de Parfum Misbranded
EMC 599 K. Sullivan Vol #: 24
EMC 600 C. Soppet Vol #: 24
2000D-1598 Voluntary Labeling for Bioengineered Foods
EMC 12023 Vinnie Vol #: 574
2000N-1396 Bioengineered Foods Consumed By Humans or Animals
EMC 11577 Vinne Vol #: 349
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
SF 12 GCF-1 Vol #: 403
2000P-1322 Food Labeling and Allergen Contamination Control
EMC 541 C. Shelleman Vol #: 30
EMC 542 C and M Fowler Vol #: 30
2001N-0548 Guidelines for Voluntary Nutrition Labeling of Raw Fruits
EMC 12 no signature Vol #: 1
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
EMC 14392 M. O'Brien Vol #: 342
EMC 14393 M. Shorts Vol #: 342
EMC 14394 C. Smith Vol #: 342
EMC 14395 S. Weiner Vol #: 342
EMC 14396 J. Jacobowitz Vol #: 342
EMC 14397 J. Bonniwell Vol #: 342
EMC 14398 M. Crawford Vol #: 342
EMC 14399 G. Williams Vol #: 342
EMC 14400 N. Klein Vol #: 342
EMC 14401 M. Reeve Vol #: 342
EMC 14402 M. Nelson Vol #: 342
EMC 14403 J. Howell Vol #: 342
EMC 14404 J. Weishaar Vol #: 342
EMC 14405 P. Valenti Vol #: 342
EMC 14406 J. Whitson Vol #: 342
EMC 14407 J. Whitson Vol #: 342
EMC 14408 M. Jacobs Vol #: 342
EMC 14409 E. Eilts Vol #: 342
EMC 14410 D. Norton Vol #: 342
EMC 14411 S. Tyler Vol #: 342
EMC 14412 M. Bratzler Vol #: 342
EMC 14413 P. Zucker Vol #: 342
2001P-0230 Domestic Marketing & Importation of Transgenic Fish
EMC 3164 T. Porcelli Vol #: 261
EMC 3165 E. Bradley Vol #: 261
EMC 3166 A. Jacus Vol #: 261
EMC 3167 C. Dymes Vol #: 261
2002N-0204 Bar Code Label Requirements for human drug products
EMC 206 P. Wyzkiewicz, RPh Vol #: 16
2002P-0317 Recall Aspartame as a Neurotoxic Drug
EMC 453 Mission Possible Intl Vol #: 7
EMC 454 Mission Possible Intl Vol #: 7
EMC 455 Calorie Control Council Vol #: 7
EMC 456 Calorie Control Council Vol #: 7
2003D-0497 Guidance for Industry on Pharmacogenomic Data Submissions
EC 3 Mr. Erdni Barinov Vol #: 2
EC 4 Mr. David Wu Vol #: 2
2003F-0088 Increase the Maximum Permitted Energy Level of X-rays
EMC 425 C. Anderson Vol #: 4
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 757 J. Ingalls Vol #: 11
EMC 758 No signature Vol #: 11
EMC 759 A. Fonfa Vol #: 11
EMC 760 A. Medel, Esq Vol #: 11
EMC 761 M. Casida Vol #: 11
EMC 762 R. Walder Vol #: 11
EMC 763 B. Roberts, MS, RD, LD Vol #: 11
EMC 764 R. Lagueux Vol #: 11
EMC 765 L. GLoede Vol #: 11
EMC 766 A. Zebrowski Vol #: 11
EMC 767 S. Ponder Vol #: 11
EMC 768 D. Fitzgerald Vol #: 11
EMC 769 V. Sumrell Vol #: 11
EMC 770 L. Osanitch Vol #: 11
EMC 771 C. Rumbut Vol #: 11
EMC 772 No signature Vol #: 11
EMC 773 D. Hiebert Vol #: 11
EMC 774 J. Rosenberg Vol #: 11
EMC 775 J. Rosenberg Vol #: 11
EMC 776 Atkins Nutritionals, Inc. Vol #: 11
EMC 777 D. Mortelliti Vol #: 11
2003P-0159 Venlafaxine Hydrochloride Extended-Release Tablets
ACK 2 Wyeth Pharmaceuticals Vol #: 2
PRC 1 Wyeth Pharmaceuticals Vol #: 2
PSA 1 Wyeth Pharmaceuticals Vol #: 2
2004D-0188 Guidance for Industry on Development and Use of Risk Minimization Action Plans
EC 4 Dr. Derik Finch Vol #: 2
2004D-0510 Live & Perishable Fish & Fishery Products for Export to the European Union and the European Free Trade Association
LET 1 HFW-1 to Honorable Olympia J. Snowe Vol #: 1
2004N-0330 Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
C 6 D. Northup Vol #: 2
2004N-0366 Working with Stakeholders on Scientific Opportunities for Facilitating Development of Vaccines, Blood and Blood Products, and Cellular, Tissue, and Gene Therapies
EC 1 Concerned Citizen Vol #: 1
2004N-0454 Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
C 166 D. Welch Vol #: 39
2004N-0456 Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
C 44 G. P.Anderson Vol #: 1
2004N-0559 Overall benefit to risk considerations for Cox-2 selective nonsteroidal anti-inflammatory drugs and related agents
C 19 A. Cox Vol #: 2
2004Q-0151 Qualified Health Claim (QHC): soy protein and cancer
EC 211 Ms. Carrol Dugan Vol #: 8
EC 212 None Vol #: 8
EC 213 Maggies Marketplace Vol #: 8
EC 214 Mr. James Smith Vol #: 8
EC 215 Mrs. Ronda Carter Vol #: 8
EC 216 Dr. William Streiff Vol #: 8
EC 217 Mrs. Rosary Bullard Vol #: 8
EC 218 Dr. Donald Schmidt Vol #: 8
EC 219 Mr. DONALD RANKIN Vol #: 8
EC 220 Mr. Thomas Houser Vol #: 8
EC 221 Mr. Dwight Custer Vol #: 8
EC 222 None Vol #: 8
EC 223 Mr. Armand Carrier Vol #: 8
EC 224 Ms. Tiffany Whitfill Vol #: 8
EC 225 Mr. Larry Lyles Vol #: 8
EC 226 Mr. Dave Johnson Vol #: 8
EC 227 Mr. David Marsh Vol #: 8
EC 228 Mr. John Kunkle Vol #: 8
EC 229 Mr. David Johnson Vol #: 8
EC 230 Mrs. Joan Kennedy Vol #: 8
EC 231 Mrs. margaret bernard Vol #: 8
EC 232 Ms. Christine Mosby Vol #: 8
EC 233 Mr. Stephen Kelley Vol #: 8
EC 234 Mr. Donald Webber Vol #: 8
EC 235 Dr. Joseph Newton Vol #: 8
EC 236 Mr. Robert Freddo Vol #: 8
EC 237 Mr. Mark Worden Vol #: 8
EC 238 Mr. RICHARD DURHAM Vol #: 8
EC 239 Mr. pat ryan Vol #: 8
EC 240 Ms. Irene Rumiancew Vol #: 8
EC 241 Mrs. Teena Eberle Vol #: 8
EC 242 Mr. Lenard Howell Vol #: 8
EC 243 Ms. Callie Wall Vol #: 8
EC 244 Mrs. RAFAELA YNIGUEZ Vol #: 8
EC 245 Mrs. Glenda Keith Vol #: 8
EC 246 Miss. Kathleen Stroman Vol #: 8
EC 247 Mr. Paul Arellano Vol #: 8
EC 248 2004Q-0151 - Qualified Health Claim: Soy Protein a Vol #: 8
EC 249 Mr. Sean Aldrich Vol #: 8
EC 250 Mr. Dorrel Nutter Vol #: 8
EC 251 Mrs. Constance Freeman Vol #: 8
EC 252 Mr. Michael Garrett Vol #: 8
EC 253 Mr. Jack Thompson Vol #: 8
EC 254 Miss. Mona Freeman Vol #: 8
EC 255 Ms. Pamela Bayless Vol #: 8
EC 256 Mr. James Horn Vol #: 8
EC 257 Dr. Richard Sherwin Vol #: 8
EC 258 Ms. Harriet Parker Vol #: 8
EC 259 Mr. Jerry Napier Vol #: 8
EC 260 Ms. S. K. Trevino Vol #: 8
EC 261 Mr. Jack Patterson Vol #: 8
EC 262 Apache County Vol #: 8
EC 263 Ms. Donald Partington Vol #: 8
EC 264 Dr. Zoe Alexander Vol #: 8
EC 265 Mr. Gustave Nickel Vol #: 8
EC 266 Mr. Bill McNamar Vol #: 8
EC 267 Mrs. Donna Schwenk Vol #: 8
EC 268 Mr. Manny Katz Vol #: 8
EC 269 Mr. John Fitzgerald Vol #: 8
EC 270 Mr. Sterling Van Gundy Vol #: 8
EC 271 Mr. Brad Hodges Vol #: 8
EC 272 Mr. Ken Sayar Vol #: 8
EC 273 Mr. Phillip Frederick Vol #: 8
EC 274 Ms. Kelly Maurie Vol #: 8
EC 275 Mrs. Linda Littlejohn Vol #: 8
EC 276 Mr. Jack Patterson Vol #: 8
EC 277 Mr. Werner Kraemer Vol #: 8
EC 278 Mr. Robert McCoon Vol #: 8
EC 279 Mrs. Ruth Lawler Vol #: 8
EC 280 Mr. ARTHUR HILVITZ Vol #: 8
EC 281 Mr. keith reinhardt Vol #: 8
EC 282 Mr. Robert Syvertsen Vol #: 8
EC 283 Ms. Rosemary Rogers Vol #: 8
EC 284 Mr. Lloyd Leiderman Vol #: 8
EC 285 Lee Silvey Counseling Vol #: 8
EC 286 Mr. Bruce Youngberg Vol #: 8
EC 287 Mr. David Rose Vol #: 8
EC 288 Mrs. Lyell McConnell Vol #: 8
EC 289 Ms. Evette Pettaway Vol #: 8
EC 290 Ms. Virginia Kennebeck Vol #: 8
EC 291 Ms. Carolyn Franks Vol #: 8
EC 292 Mr. James Rodgers Vol #: 8
EC 293 Ms. Karen Hyman Vol #: 8
EC 294 Mr. Raymond Prosser Vol #: 8
EC 295 Ms. Linda Messner Vol #: 8
EC 296 Ms. Margaret Carey Vol #: 8
EC 297 Mrs. Debbie Kirby Vol #: 8
EC 298 Ms. Diane Conley Vol #: 8
EC 299 Mrs. Donna Gosse Vol #: 8
EC 300 Mr. thomas gomperts Vol #: 8
EC 301 Mrs. Joyce Lawson Vol #: 8
EC 302 Iron Quest Fitness Vol #: 8
EC 303 Mr. mark svensen Vol #: 8
EC 304 Mrs. Sharon Inouye Vol #: 8
EC 305 Mrs. Roberta Rohn Vol #: 8
EC 306 Mrs. Ruthanne Pleasant Vol #: 8
EC 307 Ms. Sharon Garvin Vol #: 8
EC 308 Ms. Brenda Workman Vol #: 8
EC 309 Mr. Gordon Kane Vol #: 8
EC 310 Ms. Sandra Dinkins-Wilson Vol #: 8
EC 311 Mr. Martin Haak Vol #: 8
EC 312 Mr. Edward Stecher Vol #: 8
EC 313 Ms. Helen M Waters Vol #: 8
EC 314 Mr. THOMAS BROWN Vol #: 8
EC 315 N/A Vol #: 8
EC 316 none Vol #: 8
EC 317 Mr. Richard Holloman Holloman Vol #: 8
EC 318 Ms. Sandy Wilks Vol #: 8
EC 319 Ms. Diane Connelly Vol #: 8
EC 320 Mr. James Bell Vol #: 8
EC 321 Blue Jungle Import and Export LLC Vol #: 8
EC 322 Ms. Sahley Rivers Vol #: 8
EC 323 Mr. Reginald Thornton Vol #: 8
EC 324 Mr. William Hale Vol #: 8
EC 325 Mrs. Willene Johnson Vol #: 8
EC 326 N/A Vol #: 8
EC 327 Mrs. LINDA TRENHOLM Vol #: 8
EC 328 Mr. HARALD TILGNER Vol #: 8
EC 329 Mrs. Cynthia Tweedly Vol #: 8
EC 330 Metaform Foundation, Inc. Vol #: 8
EC 331 Mrs. Jackie Smith Vol #: 8
EC 332 Mr. SHELDON HABINSKY Vol #: 8
EC 333 Mr. ELMER MILLER Vol #: 8
EC 334 Ultimate Living Vol #: 8
EC 335 Mr. James Shawvan Vol #: 8
EC 336 BCI Vol #: 8
EC 337 Mr. Dave Beachler Vol #: 8
EC 338 Mrs. Shelly Hoth Vol #: 8
EC 339 Mrs. Bernice Baynes Vol #: 8
EC 340 Mr. Jack Brown Vol #: 8
EC 341 Mr. Larre Hoke Vol #: 8
EC 342 Mrs. Gale Wolsfeld Vol #: 8
EC 343 Mr. James Roma Vol #: 8
EC 344 Retired Vol #: 8
EC 345 Mrs. Carol Harper Vol #: 8
EC 346 Mr. Richard Yi Vol #: 8
EC 347 Ms. Patty Aguilera Vol #: 8
EC 348 n/a Vol #: 8
EC 349 Mr. Al Fogleman Vol #: 8
EC 350 Ms. Debra Sall Vol #: 8
EC 351 Mr. Sandy Turley Vol #: 8
EC 352 Ms. June Golem Vol #: 8
EC 353 Mr. Keith Farthing Vol #: 8
EC 354 Mrs. Cynthia Afferica Vol #: 8
EC 355 Mr. Paul Troutman Vol #: 8
EC 356 Mrs. Karen Stilson Vol #: 8
EC 357 Mr. Ronald Keel Vol #: 8
EC 358 Mr. James Carole Vol #: 8
EC 359 Mr. Richard Manasek Vol #: 8
EC 360 Downingtown Borough Councilman Vol #: 8
EC 361 Mr. Robert Unger Vol #: 8
2005D-0004 Guidance for Industry on Nonclinical Safety Evaluation of Drug Combinations
EC 2 GlaxoSmithKline Vol #: 1
EC 3 Eli Lilly and Company Vol #: 1
EC 4 Hoffmann-La Roche, Inc. Vol #: 1
EC 5 CANTOX Health Sciences International Vol #: 1
2005D-0021 International Conference on Harmonisation; Draft Guidance on Q8 Pharmaceutical Development
C 4 Jerussi Consulting, Inc. Vol #: 1
EC 2 Berlex/Schering AG Vol #: 1
EC 3 Novartis Pharmaceuticals Corporation Vol #: 1
EC 4 Bayer Healthcare, Bioogical Products Division Vol #: 1
EC 5 Genentech Vol #: 1
2005D-0022 International Conference on Harmonisation; Draft Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals
EC 2 ILSI Health and Environmental Sciences Institute Vol #: 1
2005D-0030 Guidance for Industry on Clinical Lactation Studies Study Design, Data Analysis, and Recommendations for Labeling
EC 1 Pfizer Vol #: 1
EC 2 GlaxoSmithKline Vol #: 1
EC 3 Public Citizen's Health Research Group Vol #: 1
2005D-0103 Guidance for Industry on Using a Centralized IRB Process in Multicenter Clinical Trials
C 2 J. Heubi, M.D. Vol #: 1
2005D-0155 Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials
GDL 1 Guidance Vol #: 1
NAD 1 FDA Vol #: 1
2005M-0158 Bayer Healthcare, LLC; Premarket approval for ADVIA Centaur HBc IgM ReadyPack Reagents and ADVIA Centaur HBc IgM Quality Control Materials, P030040
AAV 1 Bayer Healthcare, LLC Vol #: 1
2005M-0159 Ventana Medical Systems, Inc.; Premarket Approval of Ventana Medical Systems' Pathway Anti-c-KIT (9.7) Primary Antibody, P020055
AAV 1 Ventana Medical Systems, Inc. Vol #: 1
2005M-0160 BioGenex Laboratories, Inc., Premarket Approval of InSite Her-2/neu kit, P040030
AAV 1 BioGenex Laboratories, Inc. Vol #: 1
2005N-0038 Reporting of Adverse Events to Institutional Review Boards; Public Hearing
EC 22 Dana Farber/Partners Cancer Care Vol #: 3
EC 23 MedImmune Inc. Vol #: 3
EC 24 Univ. of Mississippi Medical Center Vol #: 3
EC 25 Dr. Jim Monolakis Vol #: 3
EC 26 University of Michigan Vol #: 3
EC 27 Baylor College of Medicine Vol #: 3
EC 28 Consortium of Independent Review Boards Vol #: 3
EC 29 AdvaMed Vol #: 3
EC 30 Stanford University Vol #: 3
EC 31 U.T. M.D. Anderson Cancer Center Vol #: 3
EC 32 Council on Governmental Relations Vol #: 3
EC 33 SUNY Human Subjects Forum Vol #: 3
EC 34 Pharm Res Vol #: 3
EC 35 Chesapeake Research Review, Inc. Vol #: 3
EC 36 Quorum Review, Inc. Vol #: 3
EC 37 Pfizer Inc Vol #: 3
EC 38 Pfizer Inc Vol #: 3
2005N-0065 Risk Assessment of the Public Health Impact from Foodborne Listeria monocytogenes in Smoked Finfish
EC 2 National Fisheries Institute Vol #: 1
2005N-0077 Color Additive Certification; Increase in Fees for Certification Services
ACK 1 HFA-305 to the International Association of Color Manufacturers Vol #: 1
ACK 2 HFA-305 to the International Association Color Manufacturers Vol #: 1
C 1 International Assn of Color Manufacturers Vol #: 1
CP 1 International Association Color Manufacturers Vol #: 1
PSA 1 International Association of Color Manufacturers Vol #: 1
2005N-0097 Agency Information Collection Activities: Proposed Collection; Comment Request;
EC 1 ABC Research Corporation Vol #: 1
2005P-0094 Remove the drug Iressa (gefitnib; AstraZeneca) from the market immediately
SUP 1 Public Citizen's Health Research Group (Public Citizen) Vol #: 1
2005P-0166 to prevent the unlawful misbanding of prescription distance glasses and contact lenses
ACK 1 HFA-305 to International Myopia Prevention Association Vol #: 1
CP 1 International Myopia Prevention Association Vol #: 1

Page created on May 11, 2005 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management